Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CYBR
276
DELISTED
CyberArk
CYBR
| $287M | 0.05% |
861,061
+245,539
| +40% | +$74.6M |
2014 Q3
41 quarters
|
|
277
CALL
Robinhood
HOOD
$101B
| $286M | 0.05% |
7,683,000
+1,605,500
| +26% | +$51.8M |
2021 Q3
13 quarters
|
|
278
CVS Health
CVS
$111B
| $286M | 0.05% |
6,366,445
+4,202,234
| +194% | +$236M |
2013 Q2
46 quarters
|
|
279
PUT
GE Aerospace
GE
$321B
| $285M | 0.05% |
1,708,200
-531,200
| -24% | -$94.8M |
2013 Q2
46 quarters
|
|
280
PUT
Chevron
CVX
$405B
| $282M | 0.05% |
1,946,900
-60,200
| -3% | -$9.21M |
2013 Q2
46 quarters
|
|
281
United Airlines
UAL
$36.5B
| $278M | 0.05% |
2,866,977
-1,025,263
| -26% | -$86.7M |
2016 Q2
34 quarters
|
|
282
Microchip Technology
MCHP
$44.2B
| $278M | 0.05% |
4,844,664
+4,661,441
| +2,544% | +$320M |
2016 Q3
33 quarters
|
|
283
AstraZeneca
AZN
$243B
| $277M | 0.05% |
2,111,409
+1,887,183
| +842% | +$264M |
2016 Q1
35 quarters
|
|
284
Applovin
APP
$89.8B
| $276M | 0.05% |
852,126
+783,039
| +1,133% | +$198M |
2021 Q2
14 quarters
|
|
285
PUT
Carvana
CVNA
$45.9B
| $275M | 0.05% |
6,756,500
-506,000
| -7% | -$22.7M |
2017 Q3
29 quarters
|
|
286
CALL
Accenture
ACN
$122B
| $274M | 0.05% |
779,900
+42,900
| +6% | +$15.4M |
2013 Q2
46 quarters
|
|
287
CALL
Western Digital
WDC
$150B
| $273M | 0.05% |
6,067,675
+1,347,476
| +29% | +$67.7M |
2013 Q2
46 quarters
|
|
288
DoorDash
DASH
$82B
| $273M | 0.05% |
1,630,000
-627,872
| -28% | -$103M |
2021 Q1
15 quarters
|
|
289
PUT
Bristol-Myers Squibb
BMY
$125B
| $273M | 0.05% |
4,827,400
-2,312,500
| -32% | -$129M |
2013 Q2
46 quarters
|
|
290
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.5B
| $272M | 0.05% |
3,020,800
+745,100
| +33% | +$72.2M |
2016 Q3
33 quarters
|
|
291
Marvell Technology
MRVL
$245B
| $271M | 0.05% |
2,453,328
+1,186,676
| +94% | +$110M |
2013 Q2
46 quarters
|
|
292
CALL
ProShares UltraPro QQQ
TQQQ
$39.4B
| $270M | 0.05% |
6,819,600
-4,273,000
| -39% | -$168M |
2016 Q3
33 quarters
|
|
293
Johnson & Johnson
JNJ
$617B
| $270M | 0.05% |
1,865,202
+1,207,406
| +184% | +$187M |
2017 Q3
29 quarters
|
|
294
Marriott International
MAR
$93.6B
| $269M | 0.05% |
963,810
-791,119
| -45% | -$217M |
2015 Q3
37 quarters
|
|
295
CALL
ARK Innovation ETF
ARKK
$9.7B
| $269M | 0.05% |
4,731,300
+652,000
| +16% | +$34.9M |
2020 Q2
18 quarters
|
|
296
CALL
State Street Industrial Select Sector SPDR ETF
XLI
$30.5B
| $268M | 0.05% |
2,033,600
+334,300
| +20% | +$46.1M |
2014 Q1
43 quarters
|
|
297
CALL
Applied Materials
AMAT
$429B
| $268M | 0.05% |
1,645,400
-92,500
| -5% | -$16.8M |
2013 Q2
46 quarters
|
|
298
PUT
GE Vernova
GEV
$263B
| $267M | 0.05% |
811,700
+350
| +0% | +$109K |
2024 Q2
2 quarters
|
|
299
PUT
iShares Bitcoin Trust
IBIT
$67.2B
| $266M | 0.05% |
+5,019,700
| New | +$237M |
2024 Q4
0 quarters
|
|
300
CALL
Vertiv
VRT
$97.1B
| $266M | 0.05% |
2,342,300
+667,800
| +40% | +$79.3M |
2022 Q4
8 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.